Connective Tissue Diseases  >>  TAK-783  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TAK-783 / Takeda
NCT00760968 / 2006-003054-26: Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis

Completed
2
224
Europe, RoW
TAK-783 and methotrexate, Rheumatrex®., Methotrexate
Takeda
Arthritis, Rheumatoid
02/09
02/09

Download Options